NICE Recommends Kuvan to Treat Children 18 and Younger
News
The National Institute for Health and Care Excellence (NICE) has issued draft guidance that recommends Kuvan (sapropterin), alongside a low-phenylalanine diet, for treating children younger than 18 who have phenylketonuria ... Read more